Prevalence and determinants of current asthma in Cameroon.


Journal

Respiratory medicine and research
ISSN: 2590-0412
Titre abrégé: Respir Med Res
Pays: France
ID NLM: 101746324

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 06 05 2020
revised: 25 07 2020
accepted: 25 07 2020
pubmed: 26 8 2020
medline: 28 9 2021
entrez: 26 8 2020
Statut: ppublish

Résumé

The prevalence of asthma varies from one country to another due to differences in ethnicity, socio-economics status, environmental and climatic risk factors. The aim of this study was to determine the prevalence and determinants of current asthma in Cameroonian adults. Data from 4 cross-sectional community-based studies from 2014 to 2018 were analyzed. Participants aged 19 years and above were selected through multilevel stratified random sampling methods across 2 urban areas, 2 semi-urban areas and 1 rural area. Current asthma was defined as "wheezing in the last 12 months in a subject with self-reported asthma or having used drugs for asthma treatment". Logistic regression was used to investigate the determinants of current asthma. A total of 10,707 adults [median age (interquartile range)=36 (26-52) years, 44.5% of men] were definitively enrolled in the study. The overall prevalence [95% confidence interval (CI)] of current asthma was 3.9% (3.5-4.3)%. Determinants [odd's ratio (OR), (95%CI)] of current asthma were: Sudanese ethnicity [1.9(1.4-2.7)], rural area [1.5(1.1-2.1)], urban area [1.6(1.2-2.2)], past history of pneumonia [1.9(1.1-3.4)], allergic rhino-conjunctivitis [6.5(4.7-8.9)], atopic eczema [2.3(1.5-3.6)], body mass index (BMI)≥40kg/m The prevalence of current asthma is close to the low value of the Sub-Saharan African range. Sudanese ethnicity, rural area, urban area, history of pneumonia, allergic disease, severe obesity and underweight were determinants of current asthma in Cameroon. More research is surely warranted to understand the mechanisms underlying the association of asthma with Sudanese ethnicity.

Identifiants

pubmed: 32841816
pii: S2590-0412(20)30039-8
doi: 10.1016/j.resmer.2020.100783
pii:
doi:

Types de publication

Historical Article Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100783

Informations de copyright

Copyright © 2020. Published by Elsevier Masson SAS.

Auteurs

A D Balkissou (AD)

Faculty of Medicine and Biomedical Sciences of Garoua, University of Ngaoundéré, Garoua, Cameroon; Hôpital Jamot de Yaounde, Yaoundé, Cameroon. Electronic address: dodobalkissou@gmail.com.

V Poka-Mayap (V)

Hôpital Jamot de Yaounde, Yaoundé, Cameroon.

M Massongo (M)

Hôpital Jamot de Yaounde, Yaoundé, Cameroon; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

A Djenabou (A)

Hôpital Jamot de Yaounde, Yaoundé, Cameroon.

L-M Endale-Mangamba (LM)

Hôpital Laquintinie de Douala, Douala, Cameroon; Faculty of Medicine and Pharmaceutical Sciences of Douala, Douala, Cameroon.

E J Olomo (EJ)

Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

J R Boulleys-Nana (JR)

Institut Supérieur de Technologie Médicale, Yaoundé, Cameroon.

L Diffo-Sonkoue (L)

Institut Supérieur de Technologie Médicale, Yaoundé, Cameroon.

R Adidigue-Ndiome (R)

Institut Supérieur de Technologie Médicale, Yaoundé, Cameroon.

A J E Alexandra (AJE)

Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

A B Haman-Wabi (AB)

Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

S Adama (S)

Institut Supérieur de Technologie Médicale, Yaoundé, Cameroon.

A Iddi-Faical (A)

Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

E W Pefura-Yone (EW)

Hôpital Jamot de Yaounde, Yaoundé, Cameroon; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH